NOVIMMUNE

Chemicals for use in the manufacture of pharmaceutical preparations used in humans and animals for the treatment of autoimmune diseases, inflammation and transplantation, including [ superantigens, ] small molecular weight compounds, polypeptides and monoclonal antibodies

Pharmaceutical preparations used in humans and animals for the treatment of autoimmune diseases, inflammation and transplantation, namely, superantigens, small molecular weight compounds, polypeptides and monoclonal antibodies; pharmaceutical and veterinary preparations for the treatment of autoimmune diseases, inflammation and for use during transplantation, including diabetes, multiple sclerosis, rheumatoid arthritis and lupus, and for immuno-modulation, namely, immuno-suppression; pharmaceutical and veterinary preparations for the modulation and control of T lymphocyte activation; [ superantigens; superantigens encoded by human endogenous retroviruses; superantigens responsible for T cell activation in autoimmune diseases; regulatory factors responsible for the control of expression of MHC class II molecules, ] regulatory factors that are directly involved in the control of T lymphocyte activation; polypeptides to treat diseases; vaccines; monoclonal antibodies to treat diseases

legal services; scientific research; chemical research; consulting in the pharmaceutical and biomedical fields